Pharmaceutical Manufacturing Industry Analysis
Cancer drug makers seek 50% price hike as platinum surge hits production viability
Cancer drug makers demand 50% price hike as platinum surge threatens treatment availability across India
Impact: 6/10
US Stocks: Apellis shares double on Biogen's $5.6 billion buyout plan
Biogen's $5.6B Apellis buyout signals M&A momentum in pharma, boosting Indian biotech talent demand and contract manufacturing opportunities.
Impact: 6/10
Centre looks to trigger 'Essentials' Act to regulate prices of bulk drugs
Government may invoke Essential Commodities Act to cap bulk drug prices, threatening pharma margins and potentially raising medicine costs for consumers
Impact: 6/10